As pressure mounts across clinical development, regulatory timelines and global supply chains, pharma and biotech leaders are being asked to deliver faster outcomes with fewer resources and greater precision. In this environment, portfolio decisions are truly strategic drivers of growth, risk and long-term value.
The upcoming Canadian Pharma & Biotech Project, Program and Portfolio Management Summit (PPM Summit Toronto), hosted by Why Summits on May 27-28, 2026, will bring together senior leaders to examine how organizations can strengthen portfolio performance and decision-making in a more constrained and complex Canadian market.
Navigating Portfolio Pressure in Canada
Life sciences organizations operating in Canada are managing a unique mix of challenges, including pricing pressures, evolving regulatory frameworks and increasing competition for global investment. At the same time, scientific innovation continues to accelerate, adding complexity to how assets are prioritized and advanced.
The Summit will explore how companies are recalibrating their portfolio strategies to manage these competing pressures, including how they balance speed, evidence and access considerations while maintaining a clear path to value creation.
From Execution to Strategic Portfolio Leadership
As organizations move beyond siloed project delivery, there is a growing emphasis on portfolio-level thinking that integrates R&D, regulatory, quality, market access and commercial priorities.
Sessions will examine how companies are establishing governance models, aligning cross-functional teams and creating decision frameworks that support more consistent and transparent portfolio outcomes. This shift is helping organizations move from reactive execution to proactive portfolio leadership.
Turning Data into Decisions
With increasing access to data, pharma and biotech companies are rethinking how decisions are made across the portfolio. Static reporting is being replaced by more dynamic approaches that use analytics and AI to model scenarios, forecast outcomes and assess risk.
The Summit will highlight practical use cases for data-driven decision-making, while also addressing challenges such as data quality, integration and governance. These discussions will help attendees identify where digital tools can support more informed and timely portfolio decisions.
Managing Risk and Resources Across the Value Chain
Balancing resources across development, manufacturing and commercialization remains a core challenge for portfolio leaders. Organizations must allocate talent, manage external partners and respond to evolving risks, from supply disruptions to regulatory changes.
The event will provide insights into how companies are optimizing resource allocation and strengthening risk management practices across global portfolios, with a focus on execution from a Canadian base.
Strengthening Canada’s Role in Global Pharma and Biotech Portfolios
Canada continues to offer strategic advantages, including strong academic institutions, diverse patient populations and established research infrastructure. However, competition for global investment, clinical programs and portfolio prioritization remains intense.
Sessions will explore how Canadian teams can better position themselves within global organizations, attract investment and play a greater role in strategic decision-making across global portfolios.
A Practical Forum for Portfolio Leaders
Designed for professionals responsible for driving project success and portfolio value, the PPM Summit Toronto offers a focused, solutions-oriented environment. Through expert-led discussions, case studies and peer exchange, attendees will gain practical insights they can apply directly within their organizations.
Register for the Summit and join peers and industry leaders to explore how data-driven decision-making, portfolio optimization and cross-functional alignment are shaping the next phase of growth in the life sciences sector.
Join or login to leave a comment
JOIN LOGIN